Potential role of chitosan, PLGA and iron oxide nanoparticles in Parkinson’s disease therapy
Abstract Background Parkinson's disease (PD) is a debilitating disease that alters an individual's functionality. Parkinsonism is a complex symptom consisting of numerous motor and non-motor features, and although several disorders are responsible, PD remains the most important. Several th...
Main Authors: | Ahmed Hafez Mousa, Salwa Agha Mohammad |
---|---|
Format: | Article |
Language: | English |
Published: |
SpringerOpen
2022-06-01
|
Series: | The Egyptian Journal of Neurology, Psychiatry and Neurosurgery |
Subjects: | |
Online Access: | https://doi.org/10.1186/s41983-022-00503-8 |
Similar Items
-
Gut Organoid as a New Platform to Study Alginate and Chitosan Mediated PLGA Nanoparticles for Drug Delivery
by: Zahra Davoudi, et al.
Published: (2021-05-01) -
Association of Indocyanine Green with Chitosan Oleate Coated PLGA Nanoparticles for Photodynamic Therapy
by: Dalila Miele, et al.
Published: (2022-08-01) -
Hyperthermia Efficacy of PEGylated-PLGA Coated Monodisperse Iron Oxide Nanoparticles
by: Fatih Senturk
Published: (2023-06-01) -
Development of chitosan-folate modified PLGA nanoparticles for targeted delivery of diosgenin as an anticancer agent
by: Fatemeh Teymouri, et al.
Published: (2024-04-01) -
Chitosan-Coated PLGA Nanoparticles Encapsulating Triamcinolone Acetonide as a Potential Candidate for Sustained Ocular Drug Delivery
by: Madhuri Dandamudi, et al.
Published: (2021-09-01)